Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs

Health Research Policy and Systems

Volumn 9, Issue , 2011, Pages

  Bridges, John F P ^a   Gallego, Gisselle ^a   Blauvelt, Barri M ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; AWARENESS; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SCREENING; CHINA; CLINICAL TRIAL; CONTROL STRATEGY; FRANCE; FUNDING; GERMANY; HUMAN; ITALY; JAPAN; KOREA; LIVER CANCER; MULTICENTER STUDY; NURSE; PERCEPTION; POLICY; PROGNOSIS; QUALITATIVE RESEARCH; RISK ASSESSMENT; SEMI STRUCTURED INTERVIEW; SPAIN; TAIWAN; UNITED STATES; VIRUS HEPATITIS;

EID: 79960656680     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-9-32     Document Type: Article

References (23)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 2010, Lyon, France: International Agency for Research on Cancer., http://globocan.iarc.fr
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-76. 10.1053/j.gastro.2007.04.061, 17570226.
3. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol 2010, 25(4):657-63. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
4. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009, 3(4):353-67. 10.1586/egh.09.35, 19673623.
5. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010, 42(Suppl 3):S206-14.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-36. 10.1002/hep.20933, 16250051.
7. Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. Journal of Gastroenterology 2009, 44(0):119-21.
8. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, et al. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis 2010, 19(3):311-7.
9. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010, 4(2):439-74. 10.1007/s12072-010-9165-7, 2900561, 20827404.
10. Lin CL, Kao JH. Optimal management of hepatocellular carcinoma: challenges and opportunities. J Gastroenterol Hepatol 2010, 25(8):1336-8. 10.1111/j.1440-1746.2010.06373.x, 20659219.
11. Shapiro DW, Lasker RD, Bindman AB, Lee PR. Containing costs while improving quality of care: the role of profiling and practice guidelines. Annu Rev Public Health 1993, 14:219-41. 10.1146/annurev.pu.14.050193.001251, 8323588.
12. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 2006, 12(45):7239-49.
13. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10(11):1111-8. 10.1016/S1470-2045(09)70241-4, 19880065.
14. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 2010, 51(3):729-33. 10.1002/hep.23561, 20186842.
15. European Hepatitis B expert group European orientation towards the Better Management of in Europe. Brussels: European Parliament 2007, European Hepatitis B expert group., http://www.hepatitisinfo.org/pdf/European_Policy_Recommendations.pdf
16. Patton MQ. Qualitative Research and Evaluation Methods. 2002, Newbury Park: Sage Publications, 3.
17. Pope C, Mays N. Qualitative methods in health and health service research. Qualitative Research In Health Care 1996, 1-9. London: BMJ Publishing Group, Mays N, Pope C.
18. Chang M-H, You S-L, Chen C-J, Liu C-J, Lee C-M, Lin S-M, et al. Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study. Journal of the National Cancer Institute 2009, 101(19):1348-55. 10.1093/jnci/djp288, 19759364.
19. Colvin HM, Mitchell AE. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Committee on the Prevention and Control of Viral Hepatitis Infections BoPHaPHP 2010, Washington D.C: National Academies Press.
20. Stickel F, Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 2010, 59(10):1303-7. 10.1136/gut.2009.199661, 20650925.
21. Bruix J, Llovet JM. Hepatocellular carcinoma: is surveillance cost effective?. Gut 2001, 48(2):149-50. 10.1136/gut.48.2.149, 1728216, 11156630.
22. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130(7):417-22.
23. Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009, 15(11):1301-14. 10.3748/wjg.15.1301, 2658831, 19294759.